Low-dose IL-2 in Established T1D - The "PROREG" Study

Clinical trial NCT03243058 · WITHDRAWN

Trial details

NCT number: NCT03243058
Sponsor: Jay S. Skyler
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Diabetes, Autoimmune

Start date: 2023-06-01
Primary completion: 2026-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.